|
參考文獻: Aoyama, T., Yamano, S., Waxman, D. J., Lapenson, D. P., Meyer, U. A., Fischer, V., Tyndale, R., Inaba, T., Kalow, W., Gelboin, H. V. & Gonzalez, F. J. Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J. Biol. Chem. 1989: 264, 10388-10395. Beato, M. Gene regulation by steroid hormones. Cell 1989: 56, 335-44. Beaune, P. H., Umbenhauer, D. R., Bork, R. W., Lloyd, R. S., Guengerich, F. P. Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase. Proc. Natl. Acad. Sci. U S A 1986: 83, 8064-8068. Bork, R. W., Muto, T., Beaune, P. H., Srivastava, P. K., Lloyd, R. S., Guengerich, F. P. Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity. J. Biol. Chem. 1989: 264, 910-919. Branch, R. A., Chern, H. D., Adedoyin, A., Romkes-Sparks, M., Lesnick, T. G., Persad, R., Wilkinson, G.R., Fleming, C. M., Dickinson, A. J., Sibley, G. et al. The procarcinogen hypothesis for bladder cancer: activities of individual drug metabolizing enzymes as risk factors. Pharmacogenetics 1995: 5, S97-102. Broly, F., Marez, D., Sabbagh, N., Legrand, M., Millecamps, S., Lo Guidice, J. M., Boone, P., Meyer, U. A. An efficient strategy for detection of known and new mutations of the CYP2D6 gene using single strand conformation polymorphism analysis. Pharmacogenetics 1995: 5, 373-384. Chiu, R., Imagawa, M., Imbra, R. J., Bockoven, J. R., Karin, M. Multiple cis- and trans-acting elements mediate the transcriptional response to phorbol esters. Nature 1987: 329, 648-51. Chodosh, L. A., Baldwin, A. S., Carthew, R. W., Sharp, P. A. Human CCAAT-binding proteins have heterologous subunits. Cell 1988: 53, 11-24. Cholerton, S., Daly, A. K., Idle, J. R. The role of individual human cytochromes P450 in drug metabolism and clinical response. Trends Pharmacol. Sci. 1992: 13, 434-439. Coon, M. J., Ding, X. X., Pernecky, S. J., Vaz, A. D. Cytochrome P450: progress and predictions. FASEB J. 1992: 6, 669-673. Daujat, M., Pichard, L., Fabre, I., Diaz, D., Maurice, M., Pineau, T., Blanc, P., Fabre, G., Fabre, J. M., Saint Aubert, B., and Maurel, P., 1990, Human P450IA and IIIA Subfamilies: Regulation of expression and inducibility in primary cultures of human hepatocytes, in: Drug Metabolizing Enzymes: Genetics, Regulation and Toxicology, Proceedings of the Eighth International Symposium on Microsomes and Drug Oxidations (Stockholm, June 25-29) (M. Ingelman-Sundberg, J.-A. Gustafsson, and S. Orrenius, eds.), p. 16. Degawa, M., Stern, S. J., Martin, M. V., Guengerich, F. P., Fu, P. P., Ilett, K. F., Kaderlik, R. K., Kadlubar, F. F. Metabolic activation and carcinogen-DNA adduct detectionin human larynx. Cancer Res. 1994: 54, 4915-9. Domanski, T. L., Liu, J., Harlow, G. R., Halpert, J. R. Analysis of four residues within substrate recognition site 4 of human cytochrome P450 3A4: role in steroid hydroxylase activity and alpha-naphthoflavone stimulation. Arch. Biochem. Biophys. 1998 : 350, 223-32. de Morais, S. M., Wilkinson, G. R., Blaisdell, J., Nakamura, K., Meyer, U. A., Goldstein, J. A. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J. Biol. Chem. 1994: 269, 15419-15422. Felix, C. A., Walker, A. H., Lange, B. J., Williams, T. M., Winick, N. J., Cheung, N. K., Lovett, B. D., Nowell, P. C., Blair, I. A., Rebbeck, T. R. Association of CYP3A4 genotype with treatment-related leukemia. Proc. Natl. Acad. Sci. U S A 1998: 95, 13176-13181. Fujii-Kuriyama, Y., Imataka, H., Sogawa, K., Yasumoto, K., Kikuchi, Y. Regulation of CYP1A1 expression. FASEB J. 1992: 6, 706-10. Fulco, A. J. P450BM-3 and other inducible bacterial P450 cytochromes: biochemistry and regulation. Annu. Rev. Pharmacol. Toxicol. 1991: 31, 177-203. Ged, C., Rouillon, J. M., Pichard, L., Combalbert, J., Bressot, N., Bories, P., Michel, H., Beaune, P., Maurel, P. The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. Br. J. Clin. Pharmacol. 1989: 28, 373-387. Gonzalez, F. J., Schmid, B. J., Umeno, M., Mcbride, O. W., Hardwick, J. P., Meyer, U. A., Gelboin, H. V., Idle, J. R. Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase. DNA 1988: 7, 79-86. Guengerich, F. P., Martin, M. V., Beaune, P. H., Kremers, P., Wolff, T., Waxman, D. J. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J. Biol. Chem. 1986: 261, 5051-5060. Guengerich, F. P. Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450. Mol. Pharmacol. 1988: 33, 500-508. Guengerich, F. P. Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene. Chem. Res. Toxicol. 1990: 3, 363-371. Guengerich, F. P., Gillam, E. M. J., Martin, M. V., Baba, T., Kim, B. R., Shimada, T., Raney, K. D., and Yun, C. H., 1994, The importance of cytochrome P450 3A enzymes in drug metabolism, in: Schering Foundation Workshop, Assessment of the Use of Single Cytochrome P450 Enzymes In Drug Research (March 23-25, Springer-Verlag Berlin), pp 161-186. Guengerich, F. P. Human cytochromes P450. In P. R. Ortiz de Montellano (ed.), Cytochromes P450: Structure, Mechanism, and Biochemistry, Plenum Press, New York, 1995, pp. 473-535. Guengerich, F. P. Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu. Rev. Pharmacol. Toxicol. 1999: 39, 1-17. Hashimoto, H., Toide, K., Kitamura, R., Fujita, M., Tagawa, S., Itoh, S., Kamataki, T. Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control. Eur. J. Biochem. 1993: 218, 585-595. He, Y. A., He, Y. Q., Szklarz, G. D., Halpert, J. R. Identification of three key residues in substrate recognition site 5 of human cytochrome P450 3A4 by cassette and site-directed mutagenesis. Biochemistry 1997: 36, 8831-9. Hunt, C. M., Westerkam, W. R., Stave, G. M. Effect of age and gender on the activity of human hepatic CYP3A. Biochem. Pharmacol. 1992: 44, 275-283. Imataka, H., Sogawa, K., Yasumoto, K., Kikuchi, Y., Sasano, K., Kobayashi, A., Hayami, M., Fujii-Kuriyama, Y. Two regulatory proteins that bind to the basic transcription element (BTE), a GC box sequence in the promoter region of the rat P-4501A1 gene. EMBO J. 1992: 11, 3663-71. Johansson, I., Yue, Q.Y., Dahl, M. L., Heim, M., Sawe, J., Bertilsson, L., Meyer, U. A., Sjoqvist, F., Ingelman-Sundberg, M. Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine. Eur. J. Clin. Pharmacol. 1991: 40, 553-6. Kalow, W., Goedde, H. W. and Agarwal, D. P. Ethnic Differences in Reactions to Drugs and Xenobiotics, AR Liss, New York, 1986. Kaminsky, L. S., Fasco, M. J. Small intestinal cytochromes P450. Crit. Rev. Toxicol. 1991: 21, 407-422. Kelly, J. D., Eaton, D. L., Guengerich, F. P., Coulombe, R. A., Jr. Aflatoxin B1 activation in human lung. Toxicol. Appl. Pharmacol. 1997: 144, 88-95. Kitada, M., Kamataki, T. Partial purification and properties of cytochrome P450 from homogenates of human fetal livers. Biochem. Pharmacol. 1979: 28, 793-797. Kitada, M., Kamataki, T., Itahashi, K., Rikihisa, T., Kanakubo, Y. P-450 HFLa, a form of cytochrome P-450 purified from human fetal livers, is the 16 alpha-hydroxylase of dehydroepiandrosterone 3-sulfate. J. Biol. Chem. 1987: 262, 13534-13537. Kolars, J., Schmiedelin-Ren, P., Dobbins, W., Merion, R., Wrighton, S., and Watkins, P. Heterogeneity of P-450 IIIA expression in human gut epithelia. FASEB J. 1990: 4, A2242. Kolars, J. C., Awni, W. M., Merion, R. M., Watkins, P. B. First-pass metabolism of cyclosporin by the gut. Lancet 1991: 338, 1488-1490. Komori, M., Hashizume, T., Ohi, H., Miura, T., Kitada, M., Nagashima, K., Kamataki, T. Cytochrome P-450 in human liver microsomes: high-performance liquid chromatographic isolation of three forms and their characterization. J. Biochem. (Tokyo) 1988: 104, 912-916. Komori, M., Nishio, K., Ohi, H., Kitada, M., Kamataki, T. Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P-450. J. Biochem. (Tokyo) 1989: 105, 161-163. Komori, M., Nishio, K., Fujitani, T., Ohi, H., Kitada, M., Mima, S., Itahashi, K., Kamataki, T. Isolation of a new human fetal liver cytochrome P450 cDNA clone: evidence for expression of a limited number of forms of cytochrome P450 in human fetal livers. Arch. Biochem. Biophys. 1989: 272, 219-225. Lai, C., Shields, P. G. The role of interindividual variation in human carcinogenesis. J. Nutr. 1999: 129 (2S Suppl), 552S-555S. Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., Kliewer, S. A. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 1998: 102, 1016-1023. Lin, Y., Anderson, G. D., Kantor, E., Ojemann, L. M., Wilensky, A. J. Differences in the urinary excretion of 6-beta-hydroxycortisol/cortisol between Asian and Caucasian women. J. Clin. Pharmacol. 1999: 39, 578-82. Lytton, S. D., Helander, A., Zhang-Gouillon, Z. Q., Stokkeland, K., Bordone, R., Arico, S., Albano, E., French, S. W., Ingelman-Sundberg, M. Autoantibodies against cytochromes P-4502E1 and P-4503A in alcoholics. Mol. Pharmacol. 1999: 55, 223-33. Marez, D., Legrand, M., Sabbagh, N., Guidice, J. M., Spire, C., Lafitte, J. J., Meyer, U. A., Broly, F. Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics 1997: 7, 193-202. Meyer, U. A. Overview of enzymes of drug metabolism. J. Pharmacokinet. Biopharm. 1996: 24, 449-59. Molowa, D. T., Schuetz, E. G., Wrighton, S. A., Watkins, P. B., Kremers, P., Mendez-Picon, G., Parker, G. A., Guzelian, P. S. Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc. Natl. Acad. Sci. U S A 1986: 83, 5311-5315. Morel, F., Beaune, P. H., Ratanasavanh, D., Flinois, J. P., Yang, C. S., Guengerich, F. P., Guillouzo, A. Expression of cytochrome P-450 enzymes in cultured human hepatocytes. Eur. J. Biochem. 1990: 191, 437-444. Muntane-Relat, J., Ourlin, J. C., Domergue, J., Maurel, P. Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology 1995: 22, 1143-1153. Murray, G. I., McFadyen, M. C., Mitchell, R. T., Cheung, Y. L., Kerr, A. C., Melvin, W. T. Cytochrome P450 CYP3A in human renal cell cancer. Br. J. Cancer 1999: 79, 1836-1842. Nelson, D. R., Kamataki, T., Waxman, D. J., Guengerich, F. P., Estabrook, R.W., Feyereisen, R., Gonzalez, F. J., Coon, M. J., Gunsalus, I. C., Gotoh, O., Okuda, K., and Nebert, D. W. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 1993: 12, 1-51. Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsalus, I. C., Nebert, D. W. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996: 6, 1-42. Ng, M. C., Young, R. P., Critchley, J. A., Leung, N. W., Lau, J. W., Li, A. K. Urinary 6 beta-hydroxycortisol excretion in Hong Kong Chinese patients with hepatocellular carcinoma and other chronic liver diseases. Cancer 1996: 77, 1427-1433. Ourlin, J. C., Jounaidi, Y., Maurel, P., Vilarem, M. J. Role of the liver-enriched transcription factors C/EBP alpha and DBP in the expression of human CYP3A4 and CYP3A7. J. Hepatol. 1997: 26 Suppl 2, 54-62. Porter, T. D., Coon, M. J. Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J. Biol. Chem. 1991: 266, 13469-13472. Rebbeck, T. R., Jaffe, J. M., Walker, A. H., Wein, A. J., Malkowicz, S. B. Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. Natl. Cancer Inst. 1998: 90, 1225-1229. Roh, H. K., Dahl, M. L., Johansson, I., Ingelman-Sundberg, M., Cha, Y. N., Bertilsson, L. Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean population. Pharmacogenetics 1996: 6, 441-7 Schuetz, J. D., Molowa, D. T., Guzelian, P. S. Characterization of a cDNA encoding a new member of the glucocorticoid-responsive cytochromes P450 in human liver. Arch. Biochem. Biophys. 1989: 274, 355-365. Schuetz, E. G., Schuetz, J. D., Grogan, W. M., Naray-Fejes-Toth, A., Fejes-Toth, G., Raucy, J., Guzelian, P., Gionela, K., Watlington, C. O. Expression of cytochrome P450 3A in amphibian, rat, and human kidney. Arch. Biochem. Biophys. 1992: 294, 206-214. Shimada, T., Martin, M. V., Pruess-Schwartz, D., Marnett, L. J., Guengerich, F. P. Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res. 1989: 49, 6304-6312. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., Guengerich, F. P. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 1994: 270, 414-423. Sladek, F. M., Zhong, W. M., Lai, E., Darnell, J. E., Jr. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 1990: 4, 2353-65. Spurr, N. K., Gough, A. C., Stevenson, K., Wolf, C. R. The human cytochrome P450 CYP3 locus: assignment to chromosome 7q22-qter. Hum. Genet. 1989: 81, 171-174. Sturm, R. A., Das, G., Herr, W. The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. Genes Dev. 1988: 2, 1582-99. Szklarz, G. D., Halpert, J. R. Molecular modeling of cytochrome P450 3A4. Comput. Aided. Mol. Des. 1997: 11, 265-72. Tateishi, T., Krivoruk, Y., Wood, A. J. J., Guengerich, F. P., and Wood, M., 1994, Identification of human liver P450 3A4 as the enzyme responsible for sulfentanil N-dealkylation, in: Abstracts, 12th Int. Congr. Pharmacol. (July 24-29, Montreal). Tran, J. Q., Kovacs, S. J., McIntosh, T. S., Davis, H. M., Martin, D. E. Morning spot and 24-hour urinary 6 beta-hydroxycortisol to cortisol ratios: intraindividual variability and correlation under basal conditions and conditions of CYP3A4 induction. Clin. Pharmacol. 1999: 39, 487-94. Vogel, F. & A. G. Motulsky: Human genetics, problems and approaches. Springer-Verlag, Berlin, 1982. Wang, H., Dick, R., Yin, H., Licad-Coles, E., Kroetz, D. L., Szklarz, G., Harlow, G., Halpert, J. R., Correia, M. A. Structure-function relationships of human livercytochromes P450 3A: aflatoxin B1 metabolism as a probe. Biochemistry 1998 : 37, 12536-45. Wang, P. P., Beaune, P., Kaminsky, L. S., Dannan, G. A., Kadlubar, F. F., Larrey, D., Guengerich, F. P. Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. Biochemistry 1983: 22, 5375-5383. Wang, S. L., Huang, J. D., Lai, M. D., Liu, B. H., Lai, M. L. Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: polymorphism in RFLP and DNA sequence of CYP2D6. Clin. Pharmacol. Ther. 1993: 53, 410-8. Watkins, P. B., Wrighton, S. A., Maurel, P., Schuetz, E. G., Mendez-Picon, G., Parker, G. A., Guzelian, P. S. Identification of an inducible form of cytochrome P-450 in human liver. Proc. Natl. Acad. Sci. U S A 1985: 82, 6310-6314. Watkins, P. B., Wrighton, S. A., Schuetz, E. G., Molowa, D. T., Guzelian, P. S. Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. Clin. Invest. 1987: 80, 1029-1036. Watkins, P. B., Turgeon, D. K., Saenger, P., Lown, K. S., Kolars, J. C., Hamilton, T., Fishman, K., Guzelian, P. S., Voorhees, J. J. Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity. Clin. Pharmacol. Ther. 1992: 52, 265-273. Wrighton, S. A., Stevens, J. C. The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol. 1992: 22, 1-21. Wrighton, S. A., VandenBranden, M., Ring, B. J. The human drug metabolizing cytochromes P450. J. Pharmacokinet. Biopharm. 1996: 24, 461-73. Yanagida, A., Sogawa, K., Yasumoto, K. I., Fujii-Kuriyama, Y. A novel cis-acting DNA element required for a high level of inducible expression of the rat P-450c gene. Mol. Cell. Biol. 1990: 10, 1470-5. Zhang, Q. Y., Dunbar, D., Ostrowska, A., Zeisloft, S., Yang, J., Kaminsky, L. S. Characterization of human small intestinal cytochromes P-450. Drug Metab. Dispos. 1999: 27, 804-9
|